Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-05

Clinical Trial Update: Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic Dermatitis [NA]

View source ↗

Summary

This entry reports an ongoing clinical trial sponsored by Biopolis S.L. evaluating a probiotic to reduce SCORAD in young patients with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (unspecified strain) (probiotic)

Snippet

Sponsor: Biopolis S.L. | Conditions: Atopic Dermatitis | NA | Status: UNKNOWN